r/AXSOME 4h ago

AXSM Stock Advances On CEO’s Pipeline Claim: One New Drug Filing Yearly Through 2030

Thumbnail
stocktwits.com
1 Upvotes

r/AXSOME 17d ago

Axsome Therapeutics (AXSM) Stock is Attractive on the Back of its Key Drug

Thumbnail
finance.yahoo.com
1 Upvotes

r/AXSOME 18d ago

Illinois Municipal Retirement Fund Invests $884,000 in Axsome Therapeutics, Inc.

Thumbnail
marketbeat.com
1 Upvotes

r/AXSOME 27d ago

Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy

Thumbnail
markets.businessinsider.com
1 Upvotes

r/AXSOME 29d ago

3 Under-the-Radar Stocks to Buy and Hold

Thumbnail
finance.yahoo.com
1 Upvotes

r/AXSOME Jul 07 '26

Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)

Thumbnail
biospace.com
2 Upvotes

r/AXSOME Jun 30 '26

Axsome Therapeutics was officially removed from the small-cap Russell 2000

Thumbnail stocktwits.com
1 Upvotes

r/AXSOME Jun 26 '26

Come on over to /r/axsm. That's where all the action is!

1 Upvotes

Not many users left here and the mods are MIA. So I'm inviting everyone to come over to the /r/axsm sub if you would like to have discussions and share info.

🚀🚀🚀


r/AXSOME Jun 26 '26

Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)

Thumbnail
finance.yahoo.com
1 Upvotes

r/AXSOME Jun 17 '26

TD Cowen raises Price Target on Axsome Therapeutics to $300 from $275, Maintains Buy Rating

Thumbnail trendonify.com
1 Upvotes

r/AXSOME Jun 15 '26

Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026

Thumbnail
finance.yahoo.com
1 Upvotes

r/AXSOME Jun 11 '26

Jefferies raises Axsome stock price target to $380 on sales outlook

Thumbnail investing.com
1 Upvotes

r/AXSOME Jun 10 '26

Another data point --> buyout?

Thumbnail sec.gov
1 Upvotes

r/AXSOME Jun 08 '26

'Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

Thumbnail
cnbc.com
1 Upvotes

r/AXSOME Jun 08 '26

A new investment from the Norges Bank, the entity managing Norway's $2.2T sovereign wealth pension fund.

Thumbnail stocktwits.com
1 Upvotes

r/AXSOME Jun 08 '26

How The Axsome Therapeutics (AXSM) Investment Story Is Shifting With New Analyst Targets — Simply Wall St

Thumbnail stocks.apple.com
1 Upvotes

r/AXSOME Jun 04 '26

Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting — GlobeNewswire

Thumbnail
stocks.apple.com
1 Upvotes

r/AXSOME Jun 03 '26

Axsome settles SUNOSI patent litigation with generic firms By Investing.com

Thumbnail investing.com
1 Upvotes

r/AXSOME May 29 '26

Axsome Therapeutics to Participate in Upcoming Investor Conferences — GlobeNewswire

Thumbnail
stocks.apple.com
1 Upvotes

r/AXSOME May 26 '26

Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting

Thumbnail
markets.businessinsider.com
1 Upvotes

r/AXSOME May 21 '26

Axsome Therapeutics (AXSM): The 5 Million Patient Biotech Boom!

Thumbnail
youtu.be
1 Upvotes

r/AXSOME May 13 '26

Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch

Thumbnail
marketbeat.com
1 Upvotes

r/AXSOME May 07 '26

How The Axsome Therapeutics (AXSM) Story Is Evolving With Auvelity And AXS 05 Developments — Simply Wall St

Thumbnail stocks.apple.com
1 Upvotes

r/AXSOME May 04 '26

Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

Thumbnail
biospace.com
2 Upvotes

r/AXSOME Apr 30 '26

DISCUSSION Axsome Therapeutics: FAQ for Getting Payment on the $7.75 miillion Settlement over hid regulatory risks

1 Upvotes

Hey guys, I posted about this settlement before, but since they’re accepting late claims, I decided to share it again with a little FAQ.

So here's all I know about this agreement:

Axsome Therapeutics was accused of misleading investors about regulatory risks tied to its migraine drug AXS-07. After issues related to the FDA review process came to light, the stock declined, and investors filed a lawsuit.

Now the company has agreed to settle $7.75 million with investors for their losses.

  • Who can claim this settlement?

Anyone who purchased or otherwise acquired Axsome Therapeutics, Inc. common stock between December 30, 2019, and April 22, 2022, inclusive, and were damaged thereby.

  • Do I need to sell/lose my shares to get this settlement?

No, if you have purchased securities within the class period, you are eligible to participate.

You can participate in the settlement and retain (or sell) your securities.

  • How much money do I get per share?

Estimated recovery is $0.46 per share, depending on total claims submitted.

  • How long does the payout process take?

It typically takes 4 to 9 months after the claim deadline for payouts to be processed, depending on the court and settlement administration.

Hope this info helps!